NCT05500027View on ClinicalTrials.gov

sCD8, as a Novel Biomarker for Pancreatic Cancer

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Serum BiomarkerPancreatic Cancer
Interventions
DIAGNOSTIC_TEST

serum test

serum test of sCD58 and TGFbeta1

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER